INS and Hyperglycemia: By contrast, another study has demonstrated that activation of VMHSF1 neurons with designer receptors exclusively activated by designer drugs (DREADD) does not induce significant hyperglycemia, but a lower blood glucose in the context of both glucose tolerance and insulin tolerance tests [118].